Could US Solve Drug Shortages With 'Heightened' M&A Scrutiny?

FDA's inter-agency drug shortage task force wants comments on whether new shortage prevention and mitigation policies should include closer examination of mergers and acquisitions that could create drug shortages.

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background

US regulators may consider intervening in pharma company mergers and acquisitions if they feel that they could create drug shortages.

In a Federal Register notice announcing a Nov. 27 public meeting on shortage prevention and mitigation, FDA's inter-agency drug shortage task force listed "heighten scrutiny of proposed mergers and...

More from US FDA

More from Agency Leadership